T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway. 2005

Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
Cattedra de Immunologia, Dipartimento de Biologia e Pathologia Cellulare e Molecolare, Naples, Italy.

Paroxysmal nocturnal haemoglobinuria (PNH) is a haematopoiesis disorder characterized by the expansion of a stem cell bearing a somatic mutation in the phosphatidylinositol glycan-A (PIG-A) gene, which is involved in the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor. A number of data suggest the inability of the PIG-A mutation to account alone for the clonal dominance of the GPI-defective clone and for the development of PNH. In this context, additional immune-mediated mechanisms have been hypothesized. We focused on the analysis of T lymphocytes in three PNH patients bearing a mixed GPI(+) and GPI(-) T cell population and showing a marked cytopenia. To analyze the biological mechanisms underlying the control of T cell homeostasis in PNH, we addressed the study of CD40-dependent pathways, suggested to be of crucial relevance for the control of autoreactive T cell clones. Our data revealed significant, functional alterations in GPI(+) and GPI(-) T cell compartments. In the GPI(-) T cells, severe defects in T cell receptor-dependent proliferation, interferon-gamma production, CD25, CD54, and human leukocyte antigen-DR surface expression were observed. By contrast, GPI(+) T lymphocytes showed a significant increase of all these parameters, and the analysis of CD40-dependent pathways revealed a functional persistence of CD154 expression on the CD48(+)CD4(+) lymphocytes. The alterations of the GPI(+) T cell subset could be involved in the biological mechanisms underlying PNH pathogenesis.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005260 Female Females
D006457 Hemoglobinuria, Paroxysmal A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins. Paroxysmal Cold Hemoglobinuria,Paroxysmal Nocturnal Hemoglobinuria,Marchiafava-Micheli Syndrome,Paroxysmal Hemoglobinuria,Paroxysmal Hemoglobinuria, Cold,Paroxysmal Hemoglobinuria, Nocturnal,Cold Paroxysmal Hemoglobinuria,Hemoglobinuria, Cold Paroxysmal,Hemoglobinuria, Nocturnal Paroxysmal,Hemoglobinuria, Paroxysmal Cold,Hemoglobinuria, Paroxysmal Nocturnal,Marchiafava Micheli Syndrome,Nocturnal Paroxysmal Hemoglobinuria,Syndrome, Marchiafava-Micheli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071178 CD48 Antigen A 40-45 KDa GPI-linked protein in the SLAM family that consists of two IMMUNOGLOBULIN C2-SET DOMAINS. It is expressed on the surface of a variety of cells with immune functions, including THYMOCYTES; mature B-LYMPHOCYTES and T-LYMPHOCYTES; NATURAL KILLER CELLS; DENDRITIC CELLS; MAST CELLS; and EOSINOPHILS. It binds to CD2 and 2B4 (CD244) receptors to activate and modulate the immunologic response. B-Lymphocyte Activation Marker BLAST-1,BCM1 Surface Antigen,Blast1 Antigen,Leukocyte Antigen MEM-102,MRC OX-45 Antigen,P41 Antigen,SLAM Family Member 2,SLAMF2 Protein,Signal-Transducing Glycoprotein-60,Signaling Lymphocytic Activation Molecule 2,Signaling Lymphocytic Activation Molecule Family Member 2,Antigen, CD48,Antigen, MRC OX-45,Antigen, P41,B Lymphocyte Activation Marker BLAST 1,Glycoprotein-60, Signal-Transducing,Leukocyte Antigen MEM 102,MEM-102, Leukocyte Antigen,MRC OX 45 Antigen,Signal Transducing Glycoprotein 60,Surface Antigen, BCM1
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
June 1987, The Medical journal of Malaysia,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
November 2020, British journal of haematology,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
August 1980, Geburtshilfe und Frauenheilkunde,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
March 1979, British journal of haematology,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
July 1972, British journal of haematology,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
January 1978, Haematologia,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
January 1972, Series haematologica (1968),
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
July 1990, British journal of haematology,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
September 2018, British journal of haematology,
Giuseppe Terrazzano, and Michela Sica, and Cristina Becchimanzi, and Silvia Costantini, and Bruno Rotoli, and Serafino Zappacosta, and Fiorella Alfinito, and Giuseppina Ruggiero
December 1982, British journal of haematology,
Copied contents to your clipboard!